Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy.
D000328:Adult; D003602:Cytotoxicity, Immunologic; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008214:Lymphocytes / Q000276:immunology*; D008297:Male; D008545:Melanoma / Q000188:drug therapy / Q000276:immunology*; D008875:Middle Aged; D011379:Prognosis; D012008:Recurrence
D003606:Dacarbazine